Handelsavisen
prelaunch
Companies Healthcare CHEK.JK
CH
CHEK.JK IDX (Jakarta) Medical Equipment, Supplies & Distribution

Chek.Jk

$133,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
11,5 %
ROE
6,6 %
Net margin
7,0 %
Debt / equity
0,09
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

CHEK.JK operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. CHEK.JK operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
6,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CHEK.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CHEK.JK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    CHEK.JK operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    CHEK.JK maintains a strong liquidity position with a current ratio of 4.41, indicating the company can easily cover its short-term liabilities with its current assets. The company holds significant cash and equivalents of 50,019,482,560, which provides a buffer against short-term obligations. However, the operating cash flow is negative at -43,150,544,260, suggesting that the company's core operations are not generating positive cash flow. The free cash flow is also negative at -4,187,527,380, indicating that the company is not generating enough cash to fund its operations and capital expenditures.

    In terms of profitability, CHEK.JK has a return on equity (ROE) of 6.64% and a return on assets (ROA) of 5.4%, which are both below the industry median for medical equipment and supplies distribution. The company's net income of 14,023,055,380 is supported by a gross profit of 77,139,953,520, but the operating income of 23,153,085,590 is relatively modest compared to its revenue of 201,306,181,380. The company's debt-to-equity ratio of 0.09 is low, indicating a conservative capital structure with minimal reliance on debt financing.

    CHEK.JK's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification in the provided data. The company's exposure to a single industry increases its vulnerability to sector-specific risks, such as regulatory changes or shifts in healthcare demand. The lack of geographic diversification data suggests that the company may be heavily reliant on a specific region, which could pose a concentration risk if that region experiences economic or political instability.

    The company's growth trajectory is not clearly defined in the provided data, as there are no specific revenue growth projections for the current or next fiscal year. However, the negative operating and free cash flows indicate that the company may be investing heavily in its operations or facing operational challenges that could impact its growth potential. The capital expenditure of -28,438,205,630 suggests that the company is making significant investments in its infrastructure or equipment, which could be a sign of expansion or modernization efforts.

    The risk assessment for CHEK.JK indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves contribute to its strong liquidity position. The risk of dilution is also low, as the number of shares outstanding for both basic and diluted shares is the same, indicating no potential for share dilution from stock options or convertible securities. The company's conservative capital structure and strong liquidity position reduce the likelihood of financial distress in the near term.

    Recent events and filings for CHEK.JK do not show any significant developments that would impact its financial position or risk profile. The absence of filing-based liquidity or dilution flags suggests that the company is maintaining a stable financial position without the need for urgent capital raising or restructuring. The company's financial statements and disclosures provide a clear picture of its operations and financial health, with no red flags indicating potential issues.

    Key takeaways
    • CHEK.JK has a strong liquidity position with a current ratio of 4.41 and significant cash reserves.
    • The company's profitability metrics, including ROE and ROA, are below the industry median.
    • CHEK.JK's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification.
    • The company is making significant capital expenditures, which could indicate expansion or modernization efforts.
    • The risk of liquidity and dilution is low, with no immediate filing-based flags detected.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $133,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $211.08B
    Net cash
    $31.74B
    Current ratio
    4.4
    Debt / equity
    0.1
    ROA
    5.4%
    ROE
    6.6%
    Cash conversion
    -308.0%
    CapEx / revenue
    -14.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin11,5 %Above median
    Net Margin7,0 %Above median
    ROE6,6 %Above median
    Capex / Rev-14,1 %Bottom quartile
    D/E0,09Above median
    Cash Conv-3,08Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • CHEK.JK Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CHEK.JKCanonical
    IDX (Jakarta) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage